- Federal government must find alternatives to rescheduling hydrocodone combination drugs
- California bill would allow pharmacists to dispense overdose remedy without prescription
- FDA to recommend rescheduling of opioid painkiller hydrocodone from CIII to CII
- QRxPharma refiles application for oxycodone, morphine combination pill Moxduo
- Mallinckrodt receives FDA approval for Xartemis XR
MAPLE GROVE, Minn. — A new opioid painkiller drug made by Upsher-Smith Labs will become available on Wednesday, the drug maker said.
Upsher-Smith said it would launch its morphine sulfate extended-release capsules in the 10-mg, 20-mg, 30-mg, 50-mg, 60-mg, 80-mg and 100-mg strengths.
The company said its product would be the first generic entrant for the 10-mg extended-release capsule dosage strength, adding that there have historically been a limited number of morphine sulfate generics available.